☰

Mariana Pedrini - Publications

Affiliations: 
Universidade Federal de São Paulo - Escola Paulista de Medicina 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Tasic L, Larcerda ALT, Pontes JGM, da Costa TBBC, Nani JV, Martins LG, Santos LA, Nunes MFQ, Adelino MPM, Pedrini M, Cordeiro Q, Bachion de Santana F, Poppi RJ, Brietzke E, Hayashi MAF. Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder. Journal of Psychiatric Research. 119: 67-75. PMID 31568986 DOI: 10.1016/J.Jpsychires.2019.09.009  0.687
2019 Boll KM, Noto C, Bonifácio KL, Bortolasci CC, Teixeira AL, Brietzke E, Pedrini M, Asevedo E, Gadelha A, Bressan RA, Barbosa DS, Maes M, Moreira EG. Corrigendum to "Oxidative and nitrosative stress biomarkers in chronic schizophrenia". Psychiatry Research. 273: 809. PMID 31185578 DOI: 10.1016/J.Psychres.2019.03.020  0.723
2019 Pedrini M, Cao B, Nani JVS, Cerqueira RO, Mansur RB, Tasic L, Hayashi MAF, McIntyre RS, Brietzke E. Advances and challenges in development of precision psychiatry through clinical metabolomics on mood and psychotic disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 30904564 DOI: 10.1016/J.Pnpbp.2019.03.010  0.768
2018 Costa TB, Lacerda A, Dal Mas C, Brietzke E, Pontes JGM, Marins L, Martins L, Nunes M, Pedrini M, S Carvalho M, Mitrovitch M, Hayashi MAF, Leite Saldanha N, Poppi RJ, Tasic L. Insights into the effects of crack abuse on the human metabolome using a NMR approach. Journal of Proteome Research. PMID 30387359 DOI: 10.1021/Acs.Jproteome.8B00646  0.499
2018 Rizzo LB, Swardfager W, Maurya PK, Graiff MZ, Pedrini M, Asevedo E, Cassinelli AC, Bauer ME, Cordeiro Q, Scott J, Brietzke E, Cogo-Moreira H. An immunological age index in bipolar disorder: A confirmatory factor analysis of putative immunosenescence markers and associations with clinical characteristics. International Journal of Methods in Psychiatric Research. e1614. PMID 29691917 DOI: 10.1002/Mpr.1614  0.766
2018 Moretti PN, Ota VK, Gouvea ES, Pedrini M, Santoro ML, Talarico F, Spindola LM, Carvalho CM, Noto C, Xavier G, Brietzke E, Gadelha A, Bressan R, Mari J, Belangero S. Accessing Gene Expression in Treatment-Resistant Schizophrenia. Molecular Neurobiology. PMID 29374346 DOI: 10.1007/S12035-018-0876-4  0.54
2018 Kegeles L, Stolz E, Mao X, Ojeil N, Massuda R, Pedrini M, Bayatmokhtari M, Slifstein M, Abi-Dargham A, Milak M, Rodriguez C, Chen C, Shungu D. 3.3 DISTURBANCES IN NEURAL OSCILLATIONS, GLUTAMATE, AND GABA: EFFECTS OF KETAMINE AND COMPARISON TO SCHIZOPHRENIA Schizophrenia Bulletin. 44: S2-S2. DOI: 10.1093/Schbul/Sby014.005  0.3
2017 Ribeiro HC, Klassen A, Pedrini M, Carvalho MS, Rizzo LB, Noto MN, Zeni-Graiff M, Sethi S, Fonseca FAH, Tasic L, Hayashi MAF, Cordeiro Q, Brietzke E, Sussulini A. A preliminary study of bipolar disorder type I by mass spectrometry-based serum lipidomics. Psychiatry Research. PMID 28918859 DOI: 10.1016/J.Psychres.2017.08.039  0.788
2017 Rios AC, Maurya PK, Pedrini M, Zeni-Graiff M, Asevedo E, Mansur RB, Wieck A, Grassi-Oliveira R, McIntyre RS, Hayashi MAF, Brietzke E. Microbiota abnormalities and the therapeutic potential of probiotics in the treatment of mood disorders. Reviews in the Neurosciences. PMID 28593878 DOI: 10.1515/Revneuro-2017-0001  0.775
2017 Mansur RB, Rizzo LB, Santos CM, Asevedo E, Cunha GR, Noto MN, Pedrini M, Zeni-Graiff M, Cordeiro Q, McIntyre RS, Brietzke E. Plasma copeptin and metabolic dysfunction in individuals with bipolar disorder. Psychiatry and Clinical Neurosciences. PMID 28457001 DOI: 10.1111/Pcn.12535  0.778
2017 Sethi S, Pedrini M, Rizzo LB, Zeni-Graiff M, Mas CD, Cassinelli AC, Noto MN, Asevedo E, Cordeiro Q, Pontes JGM, Brasil AJM, Lacerda A, Hayashi MAF, Poppi R, Tasic L, et al. (1)H-NMR, (1)H-NMR T2-edited, and 2D-NMR in bipolar disorder metabolic profiling. International Journal of Bipolar Disorders. 5: 23. PMID 28447334 DOI: 10.1186/S40345-017-0088-2  0.758
2016 Tasic L, Pontes JG, Carvalho MS, Cruz G, Dal Mas C, Sethi S, Pedrini M, Rizzo LB, Zeni-Graiff M, Asevedo E, Lacerda AL, Bressan RA, Poppi RJ, Brietzke E, Hayashi MA. Metabolomics and lipidomics analyses by (1)H nuclear magnetic resonance of schizophrenia patient serum reveal potential peripheral biomarkers for diagnosis. Schizophrenia Research. PMID 28040324 DOI: 10.1016/J.Schres.2016.12.024  0.758
2016 Brietzke E, Rosa AR, Pedrini M, Noto MN, Kapczinski F, Scott J. Challenges and developments in research of the early stages of bipolar disorder. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). 0. PMID 27533022 DOI: 10.1590/1516-4446-2016-1975  0.641
2016 Mansur RB, Santos CM, Rizzo LB, Cunha GR, Asevedo E, Noto MN, Pedrini M, Zeni M, Cordeiro Q, McIntyre RS, Brietzke E. Inter-relation between brain-derived neurotrophic factor and antioxidant enzymes in bipolar disorder. Bipolar Disorders. PMID 27488494 DOI: 10.1111/Bdi.12418  0.794
2016 Mansur RB, Santos CM, Rizzo LB, Asevedo E, Cunha GR, Noto MN, Pedrini M, Zeni-Graiff M, Cordeiro Q, Vinberg M, Kapczinski F, McIntyre RS, Brietzke E. Brain-derived neurotrophic factor, impaired glucose metabolism, and bipolar disorder course. Bipolar Disorders. 18: 373-8. PMID 27324989 DOI: 10.1111/Bdi.12399  0.773
2016 Mansur RB, Rizzo LB, Santos CM, Asevedo E, Cunha GR, Noto MN, Pedrini M, Zeni-Graiff M, Gouvea ES, Cordeiro Q, Reininghaus EZ, McIntyre RS, Brietzke E. Bipolar disorder course, impaired glucose metabolism and antioxidant enzymes activities: A preliminary report. Journal of Psychiatric Research. 80: 38-44. PMID 27281261 DOI: 10.1016/J.Jpsychires.2016.05.014  0.765
2016 Viana-Sulzbach M, Pedrini M, Bücker J, Brietzke E, Gama CS. Hippocampus size does not correlate with body mass index in bipolar disorder. Revista Brasileira De Psiquiatria (SãO Paulo, Brazil : 1999). 38: 86-7. PMID 27111704 DOI: 10.1590/1516-4446-2015-1816  0.605
2016 Mansur RB, Rizzo LB, Santos CM, Asevedo E, Cunha GR, Noto MN, Pedrini M, Zeni M, Cordeiro Q, McIntyre RS, Brietzke E. Impaired glucose metabolism moderates the course of illness in bipolar disorder. Journal of Affective Disorders. 195: 57-62. PMID 26866976 DOI: 10.1016/J.Jad.2016.02.002  0.811
2016 Mansur RB, Rizzo LB, Santos CM, Asevedo E, Cunha GR, Noto MN, Pedrini M, Zeni M, Cordeiro Q, McIntyre RS, Brietzke E. Impaired glucose metabolism moderates the course of illness in bipolar disorder Journal of Affective Disorders. 195: 57-62. DOI: 10.1016/j.jad.2016.02.002  0.807
2015 Mansur RB, Rizzo LB, Santos CM, Asevedo E, Cunha GR, Noto MN, Pedrini M, Zeni M, Cordeiro Q, McIntyre RS, Brietzke E. Adipokines, metabolic dysfunction and illness course in bipolar disorder. Journal of Psychiatric Research. 74: 63-69. PMID 26748249 DOI: 10.1016/J.Jpsychires.2015.12.003  0.784
2015 Zugman A, Pedrini M, Gadelha A, Kempton MJ, Noto CS, Mansur RB, Santoro ML, Gama CS, Bressan RA, McGuire P, Jackowski AP, Brietzke E. Serum brain-derived neurotrophic factor and cortical thickness are differently related in patients with schizophrenia and controls. Psychiatry Research. PMID 26341949 DOI: 10.1016/J.Pscychresns.2015.08.009  0.659
2014 Costa LG, Massuda R, Pedrini M, Passos IC, Czepielewski LS, Brietzke E, Gama CS. Functioning in early and late stages of schizophrenia. Trends in Psychiatry and Psychotherapy. 36: 209-13. PMID 27001021 DOI: 10.1590/2237-6089-2014-0028  0.517
2014 Pedrini M, Massuda R, de Lucena D, Macêdo D, Paz AV, Lobato MI, Belmonte-de-Abreu PS, Ceresér KM, Rocha NP, Curra MD, Panizzutti BS, Teixeira AL, Gama CS. Differences in eotaxin serum levels patients with recent onset and in chronic stable schizophrenia: a clue for understanding accelerating aging profile. Schizophrenia Research. 152: 528-9. PMID 24439271 DOI: 10.1016/J.Schres.2013.11.040  0.35
2014 Costa AB, Fontanari AM, Andreazza T, Salvador J, Koff WJ, Aguiar B, Ferrari P, Massuda R, Pedrini M, Silveira E, Belmonte-de-Abreu PS, Gama CS, Kauer-Sant'Anna M, Kapczinski F, Lobato MI. BDNF: a biomarker for social vulnerability in individuals diagnosed with gender dysphoria. Journal of Psychiatric Research. 50: 16-7. PMID 24332481 DOI: 10.1016/J.Jpsychires.2013.11.009  0.439
2014 Belmonte-de-Abreu P, Gama CS, Lobato MIR, Massuda R, Pedrini M, Fonseca M, Cristiano V. P.3.f.011 C-reactive protein associated to illness severity in schizophrenia European Neuropsychopharmacology. 24. DOI: 10.1016/S0924-977X(14)70916-2  0.305
2013 Massuda R, Bücker J, Czepielewski LS, Narvaez JC, Pedrini M, Santos BT, Teixeira AS, Souza AL, Vasconcelos-Moreno MP, Vianna-Sulzbach M, Goi PD, Belmonte-de-Abreu P, Gama CS. Verbal memory impairment in healthy siblings of patients with schizophrenia. Schizophrenia Research. 150: 580-2. PMID 24035560 DOI: 10.1016/J.Schres.2013.08.019  0.325
2013 Fontanari AM, Andreazza T, Costa ÂB, Salvador J, Koff WJ, Aguiar B, Ferrari P, Massuda R, Pedrini M, Silveira E, Belmonte-de-Abreu PS, Gama CS, Kauer-Sant'Anna M, Kapczinski F, Lobato MI. Serum concentrations of brain-derived neurotrophic factor in patients with gender identity disorder. Journal of Psychiatric Research. 47: 1546-8. PMID 23702250 DOI: 10.1016/J.Jpsychires.2013.04.012  0.556
2013 Massuda R, Pedrini M, Reckziegel R, Costanzi M, Ferrari P, Gubert C, Gama CS. Elevated serum protein oxidative stress in siblings of patients with schizophrenia. Schizophrenia Research. 147: 398-9. PMID 23664585 DOI: 10.1016/J.Schres.2013.04.025  0.317
2012 Zortéa K, da Silva Magalhães PV, Rosa AR, de Lucena DF, Guimarães LR, Petter Francesconi LP, Pedrini M, Cesar Walz J, Severino Gama C, Kapczinski F, Belmonte-de-Abreu PS. Concurrent Validity and Reliability of the Brazilian Version of the Functioning Assessment Short Test in Patients with Schizophrenia. Value in Health Regional Issues. 1: 244-247. PMID 29702907 DOI: 10.1016/J.Vhri.2012.08.001  0.483
2012 Gama CS, Canever L, Panizzutti B, Gubert C, Stertz L, Massuda R, Pedrini M, de Lucena DF, Luca RD, Fraga DB, Heylmann AS, Deroza PF, Zugno AI. Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia. Schizophrenia Research. 141: 162-7. PMID 22954755 DOI: 10.1016/J.Schres.2012.08.002  0.317
2012 Pedrini M, Massuda R, Fries GR, de Bittencourt Pasquali MA, Schnorr CE, Moreira JC, Teixeira AL, Lobato MI, Walz JC, Belmonte-de-Abreu PS, Kauer-Sant'Anna M, Kapczinski F, Gama CS. Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity. Journal of Psychiatric Research. 46: 819-24. PMID 22520512 DOI: 10.1016/J.Jpsychires.2012.03.019  0.513
2011 Pedrini M, Chendo I, Grande I, Lobato MI, Belmonte-de-Abreu PS, Lersch C, Walz J, Kauer-Sant'anna M, Kapczinski F, Gama CS. Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation. Neuroscience Letters. 491: 207-10. PMID 21256922 DOI: 10.1016/J.Neulet.2011.01.039  0.507
Show low-probability matches.